Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dystrophin pre-mRNA is a large precursor transcript whose correct processing is critical for producing functional forms of one of muscle’s most important structural proteins. Its complexity underlies both its vulnerability in genetic disease and its value as a therapeutic target through exon-skipping technologies designed at this RNA level.
Exon skipping to restore open reading frame; translational read-through of premature stop codons.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dystrophin pre-mRNA (N/A).